Testosterone therapy in men with Klinefelter syndrome has been found to improve quality of life and nearly halve mortality rates.
Prostate-specific antigen responses were similar between transdermal estradiol and hormone therapy combined with androgen receptor inhibitors in prostate cancer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback